FDA Reported Use of Patient Experience Data in 2018 Drug Approvals

Therapeutic Innovation and Regulatory Science - United States
doi 10.1177/2168479019871519
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

2017 FDA Drug Approvals

Nature Reviews Drug Discovery
MedicineDrug DiscoveryPharmacology
2018English

FDA Town Hall: New Drug Approvals in Gastrointestinal Disease (2018-2019)

Gastroenterology
HepatologyGastroenterology
2020English

Patient-Reported Outcome Claims in European and United States Orphan Drug Approvals

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Patient-Reported Outcomes in Orphan Drug Labels Approved by the US FDA

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2019English

Correction To: FDA and EMA Biosimilar Approvals

Journal of General Internal Medicine
Internal Medicine
2019English

PCN119 Patient-Reported Outcomes (PROs) in Antineoplastic Product Approvals in Europe and in the USA

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2012English

Development of a Patient Reported Experience Measure (Prem) for Use in the Ambulance Service

Emergency Medicine Journal
MedicineCritical CareEmergency MedicineIntensive Care Medicine
2015English

Use of Patient-Reported Outcomes in the Context of Different Levels of Data*

Journal of Bone and Joint Surgery - Series A
MedicineSurgeryOrthopedicsSports MedicineSports Science
2011English

Beyond the FDA PRO Guidance: Steps Toward Integrating Meaningful Patient-Reported Outcomes Into Regulatory Trials and US Drug Labels

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy